These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7497150)

  • 1. Is screening for ovarian cancer worthwhile?
    Vessey MP
    J Med Screen; 1995; 2(1):57. PubMed ID: 7497150
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer of the ovary and the hormonal context].
    Taurelle B; Laroussinie MP; Lecuru F
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(3):249-53. PubMed ID: 8345147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for ovarian cancer.
    Goswamy RK; Campbell S; Chamberlain J
    IARC Sci Publ; 1986; (76):305-9. PubMed ID: 3552976
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for ovarian carcinoma: not quite there yet.
    Vergote I; Amant F; Ameye L; Timmerman D
    Lancet Oncol; 2009 Apr; 10(4):308-9. PubMed ID: 19341965
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral contraceptives give long-lasting protection against ovarian cancer. Use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden].
    Milsom I; Odlind V
    Lakartidningen; 2008 Mar 5-11; 105(10):715-6. PubMed ID: 18422235
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics relating to ovarian cancer risk: implications for prevention and detection.
    Whittemore AS
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S15-9. PubMed ID: 7835800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and screening of ovarian cancer.
    Tortolero-Luna G; Mitchell MF; Rhodes-Morris HE
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):1-23. PubMed ID: 8015758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives and ovarian cancer: an update, 1998-2004.
    La Vecchia C
    Eur J Cancer Prev; 2006 Apr; 15(2):117-24. PubMed ID: 16523008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial ovarian cancer and combination oral contraceptives.
    Rosenberg L; Shapiro S; Slone D; Kaufman DW; Helmrich SP; Miettinen OS; Stolley PD; Rosenshein NB; Schottenfeld D; Engle RL
    JAMA; 1982 Jun; 247(23):3210-2. PubMed ID: 7045417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the association of oral contraceptives and ovarian cancer.
    Cramer DW; Hutchison GB; Welch WR; Scully RE; Knapp RC
    N Engl J Med; 1982 Oct; 307(17):1047-51. PubMed ID: 7121514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.
    Narod SA; Risch H; Moslehi R; Dørum A; Neuhausen S; Olsson H; Provencher D; Radice P; Evans G; Bishop S; Brunet JS; Ponder BA
    N Engl J Med; 1998 Aug; 339(7):424-8. PubMed ID: 9700175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and hereditary ovarian cancer.
    Kaplan RC
    N Engl J Med; 1999 Jan; 340(1):59; author reply 60. PubMed ID: 9882212
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives and hereditary ovarian cancer.
    de Souza RM; Lazzaron AR
    N Engl J Med; 1999 Jan; 340(1):59; author reply 60. PubMed ID: 9882211
    [No Abstract]   [Full Text] [Related]  

  • 15. Ovarian cancer, oral contraceptives, and BRCA mutations.
    Narod SA; Sun P; Risch HA;
    N Engl J Med; 2001 Dec; 345(23):1706-7. PubMed ID: 11759652
    [No Abstract]   [Full Text] [Related]  

  • 16. CA 125 as a screening test for ovarian cancer.
    Hakama M; Stenman UH; Knekt P; Järvisalo J; Hakulinen T; Maatela J; Aromaa A
    J Med Screen; 1996; 3(1):40-2. PubMed ID: 8861050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contraceptives as gynecological cancer prevention].
    Fukuhara R; Fukui A; Mizunuma H
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():800-4. PubMed ID: 23156353
    [No Abstract]   [Full Text] [Related]  

  • 18. Testing for ovarian cancer.
    Chan KK; Selman TJ
    Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):977-83. PubMed ID: 17116421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is screening for ovarian cancer worthwhile?
    Philip J
    J Med Screen; 1994 Oct; 1(4):206-7. PubMed ID: 8790519
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of oral contraceptives and increased risk of cervical cancer].
    Schmeink CE; Lenselink CH; Bekkers RL
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1717-8. PubMed ID: 18727601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.